BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$5.71

Market cap

$2.14B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.96

Enterprise value

$21.08B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 33

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a ...

Highlights
Bausch Health Companies's quick ratio has increased by 17% from the previous quarter and by 14% YoY
BHC's gross profit is up by 12% year-on-year and by 4.2% since the previous quarter
The company's equity has shrunk by 132% YoY but it rose by 14% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Peers: OPK ORGO

Key stats

What are the main financial stats of BHC

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
-1.72%
1 week
0.35%
1 month
-11.34%
1 year
-14.9%
YTD
-17.84%
QTD
15.82%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$10.85B
Gross profit
$7.8B
Operating income
$883M
Net income
-$1.1B
Gross margin
71.8%
Net margin
-10.1%
The operating margin has plunged by 50% YoY but it has grown by 45% from the previous quarter
The company's operating income has surged by 50% QoQ but it fell by 45% YoY
BHC's gross profit is up by 12% year-on-year and by 4.2% since the previous quarter
The net margin has increased by 12% since the previous quarter

Price vs fundamentals

How does BHC's price correlate with its fundamentals

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.2
EV/EBIT
24.23
EV/EBITDA
10.32
EV/Sales
1.94
BHC's EPS is up by 9% since the previous quarter
The company's equity has shrunk by 132% YoY but it rose by 14% QoQ
The price to sales (P/S) is 50% lower than the 5-year quarterly average of 0.4
The revenue has increased by 10% year-on-year and by 3.1% since the previous quarter

Efficiency

How efficient is Bausch Health Companies business performance
BHC's return on sales has dropped by 57% year-on-year but it is up by 11% since the previous quarter
BHC's return on invested capital has dropped by 52% year-on-year but it is up by 17% since the previous quarter
The ROA has grown by 7% from the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's total assets is 3.1% lower than its total liabilities
Bausch Health Companies's quick ratio has increased by 17% from the previous quarter and by 14% YoY
The current ratio has grown by 10% YoY and by 9% from the previous quarter
The company's equity has shrunk by 132% YoY but it rose by 14% QoQ
The debt to equity has surged by 59% year-on-year but it has declined by 16% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.